131 related articles for article (PubMed ID: 7540360)
1. [Clinical efficacy of the Porges Urospiral, a reversible intraprostatic spiral stent, in patients with benign prostatic hypertrophy].
Uchida J; Kawamura H; Fujita I; Oguchi N; Matsuda T; Ashida M; Kikkawa A; Doi T; Amazutsumi K; Ohara T
Hinyokika Kiyo; 1995 Apr; 41(4):323-8. PubMed ID: 7540360
[TBL] [Abstract][Full Text] [Related]
2. [Long-term results and indications of intraurethral stents in elderly patients with prostatic hypertrophy complaining of urinary retention].
Takeda M; Takahashi H; Tsutsui T; Go H; Hatano A; Sato S; Sasagawa T; Sakata Y; Hiraiwa M; Ando T
Hinyokika Kiyo; 1993 Nov; 39(11):1011-5. PubMed ID: 7505521
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study.
Kotsar A; Isotalo T; Juuti H; Mikkonen J; Leppiniemi J; Hänninen V; Kellomäki M; Talja M; Tammela TL
BJU Int; 2009 Mar; 103(5):626-9. PubMed ID: 18990149
[TBL] [Abstract][Full Text] [Related]
4. Urethral stent (Angiomed-Memotherm) implantation in high-risk patients with urinary retention.
Uchikoba T; Horiuchi K; Satoh M; Oka F; Saitoh Y; Tsuboi N; Nishimura T
Hinyokika Kiyo; 2005 Apr; 51(4):235-9. PubMed ID: 15912781
[TBL] [Abstract][Full Text] [Related]
5. [Urethral stent (Memotherm) for the treatment of benign prostatic hyperplasia].
Noda Y; Ujike T; Oka D; Takada S; Fujimoto N; Koide T
Hinyokika Kiyo; 2003 Nov; 49(11):645-7. PubMed ID: 14719451
[TBL] [Abstract][Full Text] [Related]
6. [Application of urethral stent under metal bougie guidance].
Isogawa Y; Ohmori K
Hinyokika Kiyo; 1993 Mar; 39(3):231-5. PubMed ID: 7685141
[TBL] [Abstract][Full Text] [Related]
7. [Transurethral hyperthermic treatment in patients with benign prostatic hypertrophy].
Yasumoto R; Kohno T; Nishikawa K; Fu O; Kawano M; Sakakura T; Kumata N; Yamamoto S; Asai Y; Yoshimura R
Hinyokika Kiyo; 1994 May; 40(5):449-54. PubMed ID: 7517623
[TBL] [Abstract][Full Text] [Related]
8. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia.
Masood S; Djaladat H; Kouriefs C; Keen M; Palmer JH
BJU Int; 2004 Dec; 94(9):1271-4. PubMed ID: 15610103
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of a metallic prostatic stent].
Yasumoto R; Yoshihara H; Kishimoto T; Maekawa M
Hinyokika Kiyo; 1991 Nov; 37(11):1467-70. PubMed ID: 1722635
[TBL] [Abstract][Full Text] [Related]
10. Prostakath in urinary outflow obstruction.
Ala-Opas M; Talja M; Tiitinen J; Hellström P; Heikkinen A; Nurmi M
Ann Chir Gynaecol Suppl; 1993; 206():14-8. PubMed ID: 7507307
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia.
Chiou RK; Chen WS; Akbari A; Foley S; Lynch B; Taylor RJ
Urology; 1996 Oct; 48(4):589-93. PubMed ID: 8886065
[TBL] [Abstract][Full Text] [Related]
12. [Outcome analysis of the urethral stent (Memotherm®)].
Sakamoto H; Matsuda A; Arakaki R; Yamada H
Hinyokika Kiyo; 2012 Jan; 58(1):13-6. PubMed ID: 22343737
[TBL] [Abstract][Full Text] [Related]
13. Placement of the urethral stent made of shape memory alloy in management of benign prostatic hypertrophy for debilitated patients.
Mori K; Okamoto S; Akimoto M
J Urol; 1995 Sep; 154(3):1065-8. PubMed ID: 7543599
[TBL] [Abstract][Full Text] [Related]
14. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
Desgrandchamps F; De La Taille A; Doublet JD;
BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
[TBL] [Abstract][Full Text] [Related]
15. Experience with a new intraurethral stent for high-risk patients with benign prostatic hypertrophy.
Fuse H; Okumura A; Sakamoto M; Katayama T
Int Urol Nephrol; 1993; 25(4):369-74. PubMed ID: 7506240
[TBL] [Abstract][Full Text] [Related]
16. [Mesh-like tubular stent treatment for chronic urinary retention caused by benign prostatic hypertrophy].
Wang X; Zhu J; Hou S
Zhonghua Wai Ke Za Zhi; 1996 Feb; 34(2):107-9. PubMed ID: 9388336
[TBL] [Abstract][Full Text] [Related]
17. Expansion and bioabsorption of the self-reinforced lactic and glycolic acid copolymer prostatic spiral stent.
Laaksovirta S; Talja M; Välimaa T; Isotalo T; Törmälä P; Tammela TL
J Urol; 2001 Sep; 166(3):919-22. PubMed ID: 11490246
[TBL] [Abstract][Full Text] [Related]
18. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study.
Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ
J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425
[TBL] [Abstract][Full Text] [Related]
19. Transurethral ethanol injection for prostatic obstruction: an excellent treatment strategy for persistent urinary retention.
Mutaguchi K; Matsubara A; Kajiwara M; Hanada M; Mizoguchi H; Ohara S; Yasumoto H; Usui T
Urology; 2006 Aug; 68(2):307-11. PubMed ID: 16904442
[TBL] [Abstract][Full Text] [Related]
20. Prostate stent is an option for selected patients who are unsuitable for transurethral resection of the prostate.
Skydsgaard Schou-Jensen K; Dahl C; Azawi NH
Dan Med J; 2014 Oct; 61(10):A4937. PubMed ID: 25283624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
